Coronary Heart Disease Diagnostic Imaging Device Market Size & Growth Forecast 2027–2036, By Segments (Modality), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Coronary Heart Disease Diagnostic Imaging Device Market size stood at USD 4.96 billion in 2026 and is predicted to grow at a 6.89% CAGR from 2027 to 2036, surpassing USD 9.66 billion by 2036. The industry revenue for 2027 is assessed at USD 5.25 billion.
Get more details on this report
Request Free Sample ReportCoronary Heart Disease Diagnostic Imaging Device Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 37.69% of the market in 2026, supported by advanced healthcare infrastructure, sophisticated imaging technologies, and investments in early cardiovascular diagnosis and hospital modernization.
- Rising cardiovascular disease burdens, expanding cardiac centers, and increasing healthcare expenditure are supporting imaging equipment investments and broader access to advanced cardiovascular diagnostics across Asia Pacific.
Segment Momentum
- Nuclear medicine accounted for 30.45% of the market in 2026, supported by its established role in myocardial perfusion assessment, cardiac function evaluation, and identifying abnormalities associated with coronary artery disease.
- Computed tomography is expected to grow fastest as improved image quality and anatomical visualization support rapid, noninvasive coronary assessment, helping clinicians evaluate suspected coronary artery disease in appropriate clinical settings.
Market Expansion Drivers
- Increasing prevalence of coronary heart disease and early diagnosis demand.
- Adoption of advanced imaging technologies (CT, MRI, and hybrid systems).
- Expansion of healthcare infrastructure and imaging centers in emerging markets.
Leading Market Participants
- Top players in the coronary heart disease diagnostic imaging device market include GE HealthCare (USA), Siemens Healthineers (Germany), Philips (Netherlands), Canon Medical Systems (Japan), Fujifilm (Japan), Hitachi Healthcare (Japan), United Imaging (China), Mindray (China), Samsung Medison (South Korea), Esaote (Italy).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 4.96 billion
- 2027 Estimated Market Size: USD 5.25 billion
- Projected Market Size: USD 9.66 billion by 2036
- Growth Forecast: 6.89% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Modality (Nuclear Medicine)
- Emerging Opportunity Segment: Modality (Computed Tomography)
Market Growth Drivers and Industry Trends
Increasing prevalence of coronary heart disease and early diagnosis demand
The growing burden of coronary heart disease is increasing the need for accurate and timely diagnostic imaging. Healthcare providers are placing greater emphasis on early detection and comprehensive assessment of cardiovascular conditions to support appropriate treatment planning and disease management. Rising awareness of cardiovascular health, increasing screening activities, and the need to identify abnormalities before complications become severe are contributing to greater utilization of diagnostic imaging devices.
Adoption of advanced imaging technologies
The adoption of advanced imaging technologies is enhancing the ability of healthcare professionals to visualize cardiac structures, blood flow, and coronary abnormalities with greater detail. Improvements in image quality, non-invasive diagnostic capabilities, and integration of multiple imaging modalities are supporting more comprehensive cardiovascular assessments. As clinicians increasingly seek accurate diagnostic information for treatment planning and monitoring, advanced imaging systems are becoming an important part of modern cardiac care.
Expansion of healthcare infrastructure and imaging centers in emerging markets
The expansion of healthcare infrastructure and diagnostic imaging facilities in emerging markets is creating new opportunities for coronary heart disease imaging devices. Investments in hospitals, specialized cardiac centers, and diagnostic facilities are improving access to advanced cardiovascular diagnostic services. Growing healthcare expenditure, increasing awareness of early diagnosis, and efforts to strengthen diagnostic capabilities are encouraging healthcare providers to expand their imaging capacity and adopt modern diagnostic equipment.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of coronary heart disease and early diagnosis demand | 3% | Short term (≤ 2 yrs) | North America; Europe | Medium | Fast |
| Adoption of advanced imaging technologies (CT, MRI, and hybrid systems) | 2.5% | Medium term (2–5 yrs) | North America; Europe; Asia Pacific | Medium | Moderate |
| Expansion of healthcare infrastructure and imaging centers in emerging markets | 1.5% | Long term (5+ yrs) | Asia Pacific; Latin America | Low | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for a 37.69% share of the coronary heart disease diagnostic imaging device market in 2026, supported by advanced healthcare infrastructure, widespread availability of sophisticated diagnostic technologies, and strong emphasis on early detection of cardiovascular conditions. Healthcare providers across the region are increasingly adopting advanced imaging solutions to improve the visualization of coronary abnormalities and support more precise clinical assessment. Growing awareness of cardiovascular disease prevention, expanding diagnostic capabilities, and continued investment in hospital modernization are contributing to demand for advanced imaging equipment. The integration of digital technologies, image-enhancement capabilities, and data-driven diagnostic workflows is further improving the efficiency of cardiovascular evaluation. In addition, established healthcare systems and increasing demand for minimally invasive diagnostic approaches are supporting the adoption of advanced coronary imaging technologies across hospitals, specialty centers, and diagnostic facilities.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region in the coronary heart disease diagnostic imaging device market, driven by increasing cardiovascular disease burdens, improving healthcare infrastructure, and expanding access to advanced diagnostic services. Healthcare systems across the region are investing in modern imaging equipment to strengthen early diagnosis and improve cardiovascular disease management. Rising healthcare expenditure, growing awareness of preventive care, and expansion of hospitals and specialized cardiac centers are creating favorable conditions for market development. Rapid urbanization and lifestyle changes are also increasing the need for efficient cardiovascular screening and diagnostic capabilities. Furthermore, technological advancements in medical imaging, greater adoption of digital healthcare solutions, and efforts to expand specialized care beyond major urban centers are supporting broader utilization of coronary heart disease diagnostic imaging devices throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Advanced Cardiac ImagingThe U.S. market prioritizes sophisticated cardiac imaging across hospitals and specialty centers, with demand shaped by diagnostic accuracy, workflow efficiency, and integration with digital clinical systems. Vendors need to support multimodality imaging, streamlined interpretation, and interoperability within increasingly technology-intensive cardiovascular care pathways.
Germany 🇩🇪
Hospital Imaging ModernizationGermany’s coronary heart disease imaging landscape emphasizes dependable diagnostic performance and efficient use of hospital imaging capacity. Suppliers can address demand through systems that combine high image quality with workflow integration, radiation-conscious protocols, and compatibility with established cardiology and radiology infrastructure.
Japan 🇯🇵
Precision Cardiac DiagnosticsJapan’s market favors precise, reliable imaging technologies that support earlier and more detailed assessment of coronary disease. Equipment priorities include compact system design, automated image analysis, efficient examination workflows, and integration with clinical environments where space and operational efficiency are important.
South Korea 🇰🇷
Technology-Enabled Cardiac ImagingSouth Korea’s cardiac imaging demand is shaped by advanced hospital capabilities and increasing use of digitally integrated diagnostic workflows. Vendors should emphasize imaging precision, rapid acquisition, automation, and connectivity with clinical information systems to support efficient cardiovascular diagnosis and specialist decision-making.
France 🇫🇷
Integrated Cardiac ImagingFrance’s coronary imaging market centers on reliable diagnosis within hospital and specialist-care pathways. Procurement priorities include clinical image quality, efficient patient throughput, interoperability with healthcare information systems, and technologies that can support consistent cardiac assessment across increasingly integrated care settings.
Italy 🇮🇹
Cardiology Imaging AccessItaly’s market focuses on strengthening cardiac diagnostic capabilities across hospitals and specialist centers while managing equipment utilization and replacement needs. Imaging providers can compete through dependable systems, efficient workflows, practical maintenance support, and solutions that fit varied clinical infrastructure requirements.
Coronary Heart Disease Diagnostic Imaging Device Market Share (%), by Modality, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportModality Segment Analysis: Nuclear Medicine (Largest Segment) vs Computed Tomography (Fastest-Growing Segment)
The nuclear medicine modality segment accounts for a 30.45% share of the coronary heart disease diagnostic imaging device market in 2026, supported by its established role in assessing myocardial perfusion, blood flow, and cardiac function. Nuclear medicine techniques provide functional information that can help clinicians evaluate how effectively blood reaches the heart muscle and identify abnormalities associated with coronary artery disease. Their use in stress testing and myocardial perfusion assessment makes them valuable for detecting ischemic conditions and supporting clinical decision-making. Continued prevalence of coronary heart disease, alongside the need for functional cardiac assessment beyond anatomical imaging, is sustaining demand for nuclear medicine-based diagnostic approaches. Improvements in imaging quality, workflow efficiency, and clinical interpretation are further supporting the modality's continued relevance.
The computed tomography modality is expected to experience the fastest growth, driven by increasing demand for rapid, high-resolution anatomical assessment of coronary arteries and cardiovascular structures. Advances in CT technology are improving image quality and enabling more detailed visualization of coronary anatomy, supporting its use in noninvasive evaluation of suspected coronary artery disease. CT-based approaches can provide clinicians with detailed anatomical information while reducing reliance on more invasive diagnostic procedures in appropriate clinical settings. Continued improvements in image acquisition, reconstruction, and motion correction are expanding the usefulness of cardiac CT, while growing emphasis on earlier and less invasive cardiovascular assessment is supporting increasing adoption of this modality.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Modality | Computed Tomography, X Rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine | Nuclear Medicine | Computed Tomography |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Manufacturers of coronary heart disease diagnostic imaging systems are competing on the intersection of diagnostic precision, patient safety, and workflow integration. While high spatial resolution remains paramount for detailed plaque characterization, equipment selection increasingly balances image clarity against aggressive radiation dose reduction protocols. Artificial intelligence plays an accelerating role by automating early plaque detection and characterization directly within reporting workflows, improving diagnostic consistency across diverse patient cohorts. To capture institutional market share, vendors must deliver open-architecture, multi-modality integration that consolidates functional and anatomical data without increasing administrative friction for clinical teams.
Key companies in the coronary heart disease diagnostic imaging device market:
- GE HealthCare (USA)
- Siemens Healthineers (Germany)
- Philips (Netherlands)
- Canon Medical Systems (Japan)
- Fujifilm (Japan)
- Hitachi Healthcare (Japan)
- United Imaging (China)
- Mindray (China)
- Samsung Medison (South Korea)
- Esaote (Italy)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare (USA) | |||||||
| Siemens Healthineers (Germany) | |||||||
| Philips (Netherlands) | |||||||
| Canon Medical Systems (Japan) | |||||||
| Fujifilm (Japan) | |||||||
| Hitachi Healthcare (Japan) | |||||||
| United Imaging (China) | |||||||
| Mindray (China) | |||||||
| Samsung Medison (South Korea) | |||||||
| Esaote (Italy) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Philips | March 2026 | Philips received FDA 510(k) clearance for its AI-powered SmartHeart, which automates cardiac MRI planning in under 30 seconds. The solution minimizes operator variability, enhances workflow consistency, reduces breath-holds to improve patient comfort, and supports faster cardiac imaging for clinical efficiency. |
| GE HealthCare | February 2026 | GE HealthCare received U.S. FDA 510(k) clearance and CE mark for Allia Moveo, a mobile, AI-enabled interventional imaging system that delivers real-time high-resolution X-ray and cone-beam CT guidance for cardiovascular and minimally invasive procedures to improve workflow efficiency and safety. |
| Canon Medical Systems | November 2025 | Canon Medical Systems received FDA 510(k) clearance for its Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, enabling diagnosis, planning, treatment, and verification within a single room to eliminate the need for patient transfers between departments. |
| Samsung | May 2024 | Samsung acquired a 100% stake in Sonio SAS, a fetal ultrasound AI software developer, to integrate specialized obstetrics and gynecology artificial intelligence assistant capabilities and advanced clinical documentation features into its ultrasound portfolio. |
| GE HealthCare | May 2024 | GE HealthCare partnered with Medis Medical Imaging to advance the development and commercialization of Medis Quantitative Flow Ratio, a non-invasive assessment tool for coronary physiology integrated into GE HealthCare's Allia Platform to streamline catheterization laboratory procedures. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Coronary Heart Disease Diagnostic Imaging Device Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Diagnostic Application | Initial Diagnosis, Risk Assessment and Screening, Treatment Planning, Post-Treatment Monitoring |
| Care Setting | Hospitals, Diagnostic Imaging Centers, Specialty Cardiology Centers, Outpatient Clinics |
Coronary Heart Disease Diagnostic Imaging Device Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Clinical Adoption Pathways |
|
| Reimbursement & Coverage Landscape |
|
| Hospital Procurement Dynamics |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market size of the coronary heart disease diagnostic imaging device market?
What is the forecasted size of the coronary heart disease diagnostic imaging device industry?
How is the growing emphasis on early coronary heart disease detection influencing imaging demand?
How is healthcare infrastructure expansion creating opportunities for advanced coronary imaging devices?
Why does nuclear medicine remain the leading imaging modality for coronary heart disease?
How is computed tomography expanding opportunities in cardiac diagnostic imaging?
Why does North America hold the largest share of the coronary heart disease diagnostic imaging device market?
How is Asia Pacific accelerating adoption of coronary heart disease diagnostic imaging devices?
Which companies are driving growth in the coronary heart disease diagnostic imaging device landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook